On Thursday, Yum! Brands, Inc. (NYSE:YUM)’s shares declined -1.13% to $90.52.
Pizza Hut, a partner of Yum! Brands, Inc. (YUM). Pizza Hut declared plans recently to make changes to its ingredients brand standards, starting with the removal of artificial flavors and colors from its nationally accessible pizzas by no later than the end of July, the first national chain to make this commitment.
For more than a year, the Pizza Hut culinary team has been working alongside its suppliers to reformulate its menu, removing many of the artificial additives that have become common across the industry supply chain. The effort has meant continuous testing and redevelopment of products, all done to preserve the flavor people have come to expect from the brand but also to meet the desire of customers who seek to know more about what’s in their food.
Pizza Hut also does not use any fillers in any of its meat toppings. Its Italian sausage is all natural and sourced from U.S. farmers, and its meatballs are free of any artificial colors, flavors or preservatives. Pizza Hut also does not add any sugar or oil to its pizza marinara sauce and its cheese is made from 100 percent whole milk mozzarella.
Also in July, Pizza Hut will introduce an interactive nutrition calculator and allergen tool to its website and mobile app that will better enable customers to tailor Pizza Hut menu items to their needs.
YUM! Brands, Inc., together with its auxiliaries, operates quick service restaurants. It operates in five segments: YUM China, YUM India, the KFC Division, the Pizza Hut Division, and the Taco Bell Division. The company develops, operates, franchises, and licenses a system of restaurants, which prepare, package, and sell various food items. As of February 4, 2015, it operated about 41,000 restaurants in about 120 countries and territories primarily under the KFC, Pizza Hut, and Taco Bell brands, which specialize in chicken, pizza, and Mexican-style food categories.
Analog Devices, Inc. (NASDAQ:ADI)’s shares dropped -0.52% to $66.94.
Analog Devices, Inc. (ADI) introduced a 2.6-GHz A/D converter engineered to address the high-bandwidth and dynamic-range needs of aerospace and defense applications. Combining giga-sample-rate speed and 75-dBc spurious-free, dynamic-range (SFDR) performance out to 1.8 GHz Ain, the AD9625BBP-2.6 12-bit A/D converter is fully optimized to match the frequency planning and signal sensitivity requirements of advanced electronic surveillance and counter-measure applications, such as radar systems, secure communications networks and electronic signals monitoring. The new converter is accessible in a tin-lead (SnPb) package that ensures high-reliability operation by eliminating the performance degradation and added cost associated with alternative packaging materials that are susceptible to tin-whiskering.
Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits (ICs) for use in industrial, automotive, consumer, and communication markets worldwide. It offers signal processing products that convert, condition, and process real-world phenomena, such as temperature, pressure, sound, light, speed, and motion into electrical signals.
At the end of Thursday’s trade, Laboratory Corp. of America Holdings (NYSE:LH)‘s shares surged 2.01% to $119.73.
Laboratory Corp. of America Holdings (LH) declared the expanded availability of its proprietary specimen collection and handling software, LabCorp AccuDraw®, to all clients through its website at www.LabCorp.com. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patient specimens throughout the specimen collection process. AccuDrawassists to facilitate collection and appropriate stabilization of the correct specimen type and sample volume. This technology-enabled solution leads to fewer errors in specimen collection and processing, a reduced chance of delays in testing, and a lower likelihood of having a patient undergo a second visit to a health care professional for further specimen collection. AccuDraw has been used in LabCorp’s patient service centers and by LabCorp’s phlebotomists located in client locations for over five years. AccuDrawhas formerly only been, and will continue to be, accessible to LabCorp clients through the LabCorp Beacon® application.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DS Healthcare Group Inc (NASDAQ:DSKX), ended its Thursday’s trading session with 23.58% gain, and closed at $2.62.
DS Healthcare Group Inc (DSKX) declared a channel incentive rewards program that will open for enrollment in July.
The program will be facilitated through a dedicated rewards website, designed exclusively for DS Healthcare, to make it easy to claim and manage rewards for participants. The rewards platform has been designed and developed to meet the unique specifications of DS Healthcare by Blackhawk Engagement Solutions - the largest provider of pre-paid solutions worldwide.
While the reward opportunities will change over time, the process of claiming for those rewards and access to those rewards will be the same. All earned rewards dollars will be loaded on a DS Healthcare branded reward card. That card may be used anywhere VISA(R) is accepted providing flexibility as to how rewards are spent.
Sales Representatives at select distributors will be able to earn rewards on their sales of DS Healthcare Personal Care products sold to stores. Reps must register in advance to take part. Registration for this program starts in July 2015.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
